Gene expression profiling in the post-mortem human brain - No cause for dismay

Journal of Chemical Neuroanatomy

Volumn 22, Issue 1-2, 2001, Pages 79-94

  Bahn, S ^a,b,d   Augood, S J ^c   Ryan, M ^b   Standaert, D G ^c   Starkey, M ^b   Emson, P C ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b United Kingdom Human Genome Mapping Project Resource Centre   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Expression profiling; Laser capture microdissection; Molecular biology; Neuropsychiatric disorders; Post mortem

Indexed keywords

ANTIGEN; MESSENGER RNA;

AUTORADIOGRAPHY; BRAIN TISSUE; CADAVER; CELL FUNCTION; COMPARATIVE STUDY; FINGER DERMATOGLYPHICS; GEL ELECTROPHORESIS; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; NEUROLOGIC DISEASE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TECHNIQUE;

EID: 0034933163     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(01)00099-0     Document Type: Article

References (94)

1. Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy
2. Frontal lobe dysfunction in progressive supranuclear palsy: Evidence for oxidative stress and mitochondrial impairment
3. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
4. Cellular localisation of enkephalin gene expression in MPTP-treated cynomolgus monkeys
5. Identified cholinergic neurones in the adult rat brain are enriched in GAP-43 mRNA: A double in situ hybridisation study
6. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellular in situ hybridization study
7. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease
8. Expression of the early-onset torsion dystonia gene (DYT1) in human brain
9. Localization of dopaminergic markers in the human subthalamic nucleus
10. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis-preliminary findings
11. Pre- and postmortem influences on brain RNA
12. Mitochondria, free radicals, and neurodegeneration
13. Post-mortem structural analyses of schizophrenic brain: Study designs and the interpretation of data
14. Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia
15. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
16. GABA(B) receptor heterodimer-component localisation in human brain
17. Laser capture microdissection: Molecular analysis of tissue
18. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia
19. The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons
20. Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease
21. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease
22. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
23. High throughput analysis of gene expression in the human brain
24. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
25. Large-scale identification of secreted and membrane-associated gene products using DNA microarrays
26. Characterization of the human cDNA and genomic DNA encoding CART: A cocaine- and amphetamine-regulated transcript
27. Library subtraction of in vitro cDNA libraries to identify differentially expressed genes in scrapie infection
28. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease
29. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: A study of complexin mRNAs
30. Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex
31. Cluster analysis and display of genome-wide expression patterns
32. Laser capture microdissection
33. Data management and analysis for gene expression arrays
34. Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease
35. Immuno-LCM: Laser capture microdissection of immunostained frozen sections for mRNA analysis
36. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease
37. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons
38. Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue
39. Subtractive cDNA cloning using oligo(dT)30-latex and PCR: Isolation of cDNA clones specific to undifferentiated human embryonal carcinoma cells
40. Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: A quantitative cellular in situ hybridisation study
41. Expression of messenger RNA for somatostatin receptor subtype 4 in adult rat brain
42. Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease
43. Terminal coma affects messenger RNA detection in post mortem human temporal cortex
44. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and comparison with their encoded proteins
45. Gene expression and neuronal activity in schizophrenia: A study of polyadenylated mRNA in the hippocampal formation and cerebral cortex
46. Light microscopic localization of brain opiate receptors: A general autoradiographic method which preserves tissue quality
47. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum
48. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
49. Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning
50. Increase in activin beta A mRNA in rat hippocampus during long-term potentiation
51. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR
52. Molecular cloning of a novel mRNA (neuronatin) that is highly expressed in neonatal mammalian brain
53. Human striatal dopamine receptors are organized in compartments
54. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene
55. Tissue pH as an indicator of mRNA preservation in human post-mortem brain
56. Analysis of segmental renal gene expression by laser capture microdissection
57. Neuropeptide Y, somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: A combined immunocytochemical and enzyme histochemical study
58. Comparative gene-expression analysis
59. Whole genome analysis: Experimental access to all genome sequenced segments through larger-scale efficient oligonucleotide synthesis and PCR
60. Biological stability of mRNA isolated from human postmortem brain collections
61. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
62. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1
63. Identifying changes in gene expression in the nervous system: mRNA differential display
64. Protein microarrays for gene expression and antibody screening
65. Gene expression profiles of laser-captured adjacent neuronal subtypes
66. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
67. A simple and efficient method for the isolation of differentially expressed genes
68. Genetic approaches to memory storage
69. Regional and cellular distribution of the P2Y(1) purinergic receptor in the human brain: Striking neuronal localisation
70. Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration
71. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines
72. Quantitative autoradiography of neurotransmitter receptors in Huntington disease
73. Localization of metabotropic glutamate receptor type 2 in the human brain
74. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia
75. Brain banking and the human hypothalamus - Factors to match for, pitfalls and potentials
76. On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease
77. Genome analysis with gene expression microarrays
78. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes
79. Stability of RNA transcripts in post-mortem psychiatric brains
80. Improved method for detecting differentially expressed genes using cDNA indexing
81. Laser-capture microdissection: Opening the microscopic frontier to molecular analysis
82. Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection
83. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: Genes associated with familial Parkinson's disease
84. Serial analysis of gene expression
85. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis
86. An improved approach to prepare human brains for research
87. Regional and cellular localisation of GABA(A) receptor subunits in the human basal ganglia: An autoradiographic and immunohistochemical study
88. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease
89. Arbitrarily primed PCR fingerprinting of RNA
90. Distribution of voltage-gated sodium channel alpha-subunit and beta- subunit mRNAs in human hippocampal formation, cortex, and cerebellum
91. Cloning of a gene whose expression is increased in scrapie and in senile plaques in human brain
92. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
93. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias
94. Biomedical discovery with DNA arrays